A year after reducing half of its workforce, Allakos will downsize to just 15 employees as it halts the development of AK006.
Despite long COVID’s vast reach, and more than $1 billion spent on research, no new treatments have been brought to market.
The allergy and immunology community mourns the loss of Marcus Maurer, MD, executive director of the Institute of Allergology ...
Mind-body therapies like meditation, psychotherapy, and deep breathing may help reduce stress levels, potentially reducing ...
What challenges could Celldex face in the competitive landscape for urticaria treatments? While barzolvolimab has shown promising efficacy, Celldex faces a competitive landscape in the urticaria ...
Along with claiming the lives of 1.2 million Americans, the COVID-19 pandemic has been described as a mass disabling event.
It was the best of biotech times, it was the worst of biotech times: One company soars, another stumbles and a third outlines ...
We all know those people. The ones who have trouble with the cold. The ones who seem surprised it’s cold every winter, but who still choose to live in Northeast Ohio.